Introduction {#sec1-1}
============

Traditional medicines provide for about 80% of health care in world populations, especially in the developing countries (Bodeker and Kronenber, 2002). In addition, plant-derived compounds have played an important key role in drug discovery. Several plants including their isolated compounds have been reported to inhibit malaria parasite (Oliveira, 2009).

Malaria is currently a public health concern in many countries due to factors such as the emerge of resistance, poor hygienic conditions, poorly managed vector control programs and no available approved vaccines (Onguene et al., 2013).

Malaria is a disease that is transmitted through the bite of a female *Anopheles* mosquito, which is infected by protozoa of genus *Plasmodium*. It is still endemic in most parts of Indonesia (WHO, 2015). Elyazar et al., 2011 summarized the distribution of *P. Palciparum, P.vivax, P. malariae*, and *P. ovale* among Indonesian population during the year of 1900-2009 was 5.8; 4.9; 0.2 and 0.005 % respectively. Those data showed that *P. falciparum* was the highest cause among the reported infection cases. The morbidity and mortality on malaria cases in Indonesia are routinely under-reported. The WHO estimated that there were 2.5 million cases of malaria in Indonesia in 2006 and over 3000 deaths had occurred in the year of 2006 (Elyazar et al., 2011).

Malaria eradication program has been carried out to suppress the morbidity and mortality caused by malaria, including early diagnosis, prompt treatment, proper surveillance and vector control. However, it also impacted on the increasing of drug resistance cases, (WHO, 2016). A new antimalarial drug to overcome such resistance is absolutely required.

Medicinal plants are potential resources for the search of antimalarial agents. Plants which are belonging to genus of *Cassia* have been reported possess strong inhibition against malaria parasite (Abdulrazak et al., 2015; Ekasari et al., 2009; Morita et al.,2007).

*Cassia* Linn. is a major genus of *Caesalpiniaceae* family. It has 600 species and some of which are widely distributed worldwide especially in tropical countries such as India (Dave and Ledwani, 2012; Viegas et al, 2004). They are also widely distributed in tropical and subtropical regions and have been used as traditional folk medicine, particularly for treatment of fever and malaria (Dave and Ledwani, 2012).

Other study reported on the chemical constituents of genus *Cassia*. The secondary metabolites of *C. spectabilis*, *C. siamea*, *C. fistula*, *C. biflora* and *C. hirsute* have been identified including alkaloids, tannins, saponins, flavonoids, carbohydrates, proteins, steroids, terpenoids, cardiac glycosides and phlobatannins (Usha and Bopaiah, 2011)

Our previous study has been reported on one of the plants from the genus *Cassia* in Indonesia, i.e. *C. siamea* that exhibited antimalarial activity. The isolated compound, namely Cassiarin A, revealed to effectively inhibit the growth of malaria parasites with IC~50~ value of 0.005 µg / mL and ED~50~ value of 12.17 mg/kg body weight (Morita et al, 2007; Ekasari et al., 2009).

Our previous screening on antimalarial activities of different nine plant species from the genus of *Cassia* showed that *C. spectabilis* produced the highest inhibition against malaria parasite (Ekasari et al, 2015). *In vitro* analysis revealed that methanol extract of leaves from *C. spectabilis* showed the strongest antimalarial activity against *P. falciparum* with IC~50~ value of 2.66 µg/mL. Moreover, its ethanolic extract also inhibits the growth of the *P.berghei in vivo* by 59. 29% (at dose of 100 mg/kg bodyweight). Further investigation on posible compounds which contributed to its antimalarial activities, revealed that only leaves of *C. spectabilis* possess an alkaloid compounds (Ekasari et al., 2009). However, other study also reported the isolated compounds from *C. spectabilis* including beta-sitosterol, betulinic acid, caffein, dihidroksi calamenen, 1,8-dihydroksi-3-metyl-6-metoksi antraquinon, friedelin, oleanolic acid, alkaloid piperidin, spectaline, stigmasterol; 1,3,8-trihidroksi-2-methylantraquinone and ursolic acid (Subramananion et al., 2012).

Determination of an effective dose that causing a higher inhibitory effect is needed before the extract can be used as an antimalarial drug. First step is to define ED~50~ value of the ethanolic extract of *C. spectabilis* leaves against *P. berghei* in mice by giving the *P. berghei*-infected mice with the extract based on Munos et al (2000). Further, based on this value the extract will be given in a single and multiple doses. The multiple doses are given to extend the therapeutic activity of the extract. Plasma level of the drug is maintained as therapeutic range to achieve its maximal effectivity, therefore, multiple doses are given in order to maintain its plasma level relatively constant. The rules of drug dosing is to give the ideal plasma level without any fluctuation and excesssive accumulation of the drug (Shargel et al., 2005).

Materials and Methods {#sec1-2}
=====================

Plant Material {#sec2-1}
--------------

The leaves of *C. spectabilis* were collected from Purwodadi Botanical Garden, East Java, Indonesia and specimen was deposited as the herbarium (Number : 525/IPH.3.04/HM/IV/2015)

Rodent's parasite {#sec2-2}
-----------------

The chloroquine sensitive *P. berghei* ANKA strain was obtained from Institute of Biomolecular Eijkmann, Jakarta, Indonesia. Mice were maintained at Malaria Laboratorium, Faculty of Pharmacy, Airlangga University, Indonesia. The percentage of parasitaemia of mice donor was examined through gram staining of mice-infected blood. Blood was collected from the mice with high parasitaemia and deposited for the use of next infection.

Inoculum of erythrocytes infected with *P.berghei* was prepared by determining the percentage parasitaemia of mice donor and diluting the blood with alceivers solutions with predetermined proportion. The mice were infected intraperitonially with 200µL of 5% parasite-containing blood from frozen deposits. Once the percent of parasitaemia reached 20%, the mice blood was taken intracardially and diluted with PBS up to 1% parasitaemia. The test mice were further infected with200µL of this parasite-containing blood with 1% parasitaemia (Widyawaruyanti et al., 2014).

Animals {#sec2-3}
-------

Adult male Balb-C mice with 20-30 g bodyweight were obtained from Pusat Veterinaria Farma (PUSVETMA) Surabaya. The mice were fed with mice pellet diet and given free access to clean drinking water. The animals allowed to acclimatize for two weeks before treated. The permission and approval for animal studies were obtained from Faculty of Veterinary Medicine, Airlangga University.

Preparation of Extract {#sec2-4}
----------------------

The leaves of *C. spectabilis* were cleaned, shade dried for four days and pulverized to produce powder. One kilogram of the dried leaf powder was extracted with 5 L of 90% ethanol using maceration method.

Antimalarial Activity {#sec2-5}
---------------------

Antimalarial activities were performed by *in vivo* experiment in mice. In order to determine ED~50~, animals were divided into seven groups of five mice, one was negative control group and six were treated groups. The negative control group was given CMC Na 0,5% once a day orally, and treated groups were fed with suspension of 90% ethanol extract of *C. spectabilis* leaves with the dose of 50, 75, 100, 150, 200 and 250 mg/kg body weight of mice once a day orally.

Further investigation to determine the effective dose of extract was also performed. Two kind of experiments were conducted in parallel. First, the ethanol extract of *C.spectabilis* leaves was administered in multiple doses (twice and thrice daily). Second, it was administered in single dose (once daily) orally at a dose of 150 mg/kg of body weight.

Antimalarial activity of ethanol extract of *C. spectabilis* leaves were conducted by *4-day suppressive test* of Peters (Phillipson and Wright, 1991). Each mouse was inoculated intraperitonially on the first day (day 0/ D0) with 0.2 ml of *P. berghei*-infected blood (1%), and followed by treatment of the malarial- infected mouse with ethanol extract of *C. spectabilis* in concentration of 50, 75, 100, 150, 200 or 250 mg/kg bodyweight. The extract was administered orally for four consecutive days.

On the fourth day after treatment (D4), the percentage of parasitaemia in *P. berghei*--infected mouse was evaluated by collecting blood from the tail of mice, and the parasitaemia was examined by gram staining. Parasitaemia level was determined by counting the number of parasite--infected erythrocytes per 3000 erythrocytes, and the ED~50~ was calculated by probit analysis. The ED~50~ representing 50% suppresion of parasite when it is compared to untreated control.

Average percentage of parasite's inhibition was calculated as following :
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X~e~ = % parasitaemia growth of the treated

X~k~ = % parasitaemia growth of negatif control

Results {#sec1-3}
=======

The results of *in vivo* antimalarial activity of ethanol extract of *C. spectabilis* leaves against *P. berghei* is presented in [Table 1](#T1){ref-type="table"}, [Table 2](#T2){ref-type="table"} and [Table 3](#T3){ref-type="table"}. The percentage of parasitaemia was observed from day 0 to day 4 post treatment ([Table 1](#T1){ref-type="table"}).

###### 

The percentage parasitaemia value of mice infected-*P. berghei* treated with ethanol extract of *C. spectabilis* leaves perorally

  Sample (mg/kg body weight)   Average parasitemia (%)                                        
  ---------------------------- ------------------------- ----------- ----------- ------------ ------------
  Neg. control                 1.22± 0.71                5.24±2.52   5.59±3.56   16.54±4.28   21.77±4.83
  50                           1.57±2.16                 3.28±2.27   6.57±3.23   11.15±2.56   15.74±3.14
  75                           2.11±1.47                 3.83±2.94   6.02±3.54   10.93±4.05   15.85±4.61
  100                          1.88±1.57                 4.35±3.85   7.49±6.32   10.48±6.27   13.47±6.40
  150                          1.30±1.23                 4.34±2.60   5.73±2.69   7.11±2.18    11.29±3.21
  200                          1.26±0.75                 3.95±1.39   4.69±0.99   8.16±3.83    9.89±2.70
  250                          0.51±0.40                 2.51±0.99   4.64±0.96   5.92±1.70    6.90±1.67

Data were obtained from average of 5 replications. D~0~-D~4~: Observation of percentage parasitaemia from day 0 (D0) until Day 4 (D4) post treatment.

###### 

The average percentage of growth and the inhibition of mice infected-*P. Berghei* treated with ethanol extract of *C. spectabilis* leaves perorally.

  Sample (mg/kg body weight)   Average percentage of growth   Average percentage inhibition   ED~50~ (mg/kg bodyweight)
  ---------------------------- ------------------------------ ------------------------------- ---------------------------
  Negative control             20.55± 5.01                    \-                              131,5
  50                           14.17± 3.25                    31.05 ± 15,82                   
  75                           13.74± 3.55                    33.13 ± 17,26                   
  100                          11.59± 6.07                    43.60 ± 29,56                   
  150                          9.99± 2.59                     51.38 ± 12,58                   
  200                          8.62± 2.18                     58.04 ± 10,59                   
  250                          6,39± 1.82                     68,91 ± 8,84                    

Data were obtained from 5 replications.

###### 

*In vivo* inhibition of mice infected-*P. berghei* treated with ethanol extract of *Cassia spectabilis* leaves at single dose(150 mg/kg body weight) and multiple dose (2 x150 mg/kg body weight and 3 x 150 mg/kg body weight) during 4 days

  Sample mg/kg bodyweight   Rep   D0     D4      Percentage of growth   Average of percentage growth   percentage inhibition   Average of percentage inhibition
  ------------------------- ----- ------ ------- ---------------------- ------------------------------ ----------------------- ----------------------------------
  Negative control          1     1.25   8.28    7.03                   7.03± 1.18                     \-                      \-
                            2     0.55   10.07   9.52                                                  \-                      
                            3     2.48   8.84    6.36                                                  \-                      
                            4     1.29   8.32    7.03                                                  \-                      
                            5     0.77   7.01    6.24                                                  \-                      
                            6     1.28   7.28    6.00                                                  \-                      
                                                                                                                               
  150                       1     2.17   6.37    4.20                   3.78± 0.27                     40.26                   46.25±3.83
                            2     1.40   5.35    3.95                                                  43.81                   
                            3     1.32   5.17    3.85                                                  45.23                   
                            4     2.25   5.68    3.43                                                  51.21                   
                            5     1.75   5.53    3.78                                                  46.23                   
                            6     1.62   5.08    3.46                                                  50.78                   
                                                                                                                               
  2x 150                    1     3.12   5.57    2.45                   3.33± 0.50                     65.15                   52.58± 7.18
                            2     1.54   4.81    3.27                                                  53.49                   
                            3     0.94   5.13    4.19                                                  40.10                   
                            4     1.91   5.22    3.31                                                  52.92                   
                            5     1.61   5.04    3.43                                                  51.21                   
                            6     1.83   5.16    3.33                                                  52.63                   
                                                                                                                               
  3x150                     1     1.94   5.10    3.16                   2,64± 0.29                     55.05                   62.42±1,62
                            2     1.66   4.50    2.66                                                  62.16                   
                            3     1.73   4.36    2.63                                                  62.59                   
                            4     0.99   3.58    2.59                                                  63.16                   
                            5     1.62   4.42    2.62                                                  62.73                   
                            6     1.89   4.08    2.19                                                  68.85                   

The percentage parasitaemia of negative control was dramatically increased after three day (D3) and four day (D4) post treatment with parasitaemia level of16.54±4.28% and 21.77±4.83%, respectively. A significant reduction of parasitaemia was observed by treatment at dose of 150 mg/kg body weight in D4 which showed percentage inhibitory of 51.38±12.58 % ([Table 2](#T2){ref-type="table"}). The result indicated that the dose of 150mg/kg bodyweight of extract possess strong inhibition against *P. berghei*.

Further analysis to determine the effective dose showed that multiple dose administration daily produced higher inhibition with percentage inhibitory of 52.58± 7.18 and 62.42±1,62 %, (twice and thrice daily respectively). Those were higher than the single administration which was 46.25±3.83% ([Table 3](#T3){ref-type="table"}).

Discussion {#sec1-4}
==========

Medicinal plants are potential resources for antimalarial agent. Preliminary study of *C. spectabilis* reported the antimalarial activities of this plant and proved to be a promising candidate for antimalarial agent. Further analysis was conducted in this study to determine the effectiveness of ethanol extract of *C. spectabilis* in the animal test.

*In vivo* analysis to *P. berghei*-infected mice was conducted by adopting method of Munoz et al. (2000) which applied some dose modification. The *P. berghei*-infected mice were treated with *C. spectabilis* extract in dose range of 50-250 mg/kg body weight.The results showed dose dependent mode of inhibition and 50% inhibition was obtained by the dose of ≤150 mg/kg bodyweight ([Table 1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}). The dose of 250 mg/kg produced the highest inhibitory (68.91%), while those that received 200 and 150 mg/kg body weight exhibited inhibitory of 58.04 ± 10,59% and 51.38 ± 12,58%, respectively ([Table 2](#T2){ref-type="table"}). These results suggested that ethanol extract of *C. spectabilis* leaves can be categorized as good antimalarial activity, with \>50% inhibitory effect achieved at dose of 250 mg/kg (Munoz et al., 2000). Other study (Bantie et al.,2014), classified extracts which have more than 50% percentage inhibitory value in *in vivo* antimalarial test with doses of 500, 250 and 100 mg/kg of body weight as moderate, good and excellent activity, respectively.

According to those classifications, the activity of ethanol extract of *C. spectabilis* leaves can be classified as good antimalarial activity. The ED~50~ of ethanol extract of *C. spectabilis* was 131.5 mg/kg body weight ([Table 2](#T2){ref-type="table"}). Therefore, the dose of 150 mg/kg body weight was used to determine the effectiveness as antimalarial agent.

The study was continued by investigating the administration of ethanol extract of *C. spectabilis* in multiple-dose and single dose with dose of 150 mg/kg body weight. The result showed that the growth percentage of *P. berghei* for multiple doses (2 or 3 times a day) were lower than single dose.The lowest growth shown for thrice daily. This means that the extract administered in multiple doses is more effective inhibiting the growth of the parasite compared to single dose. Multiple doses administration could maintain the optimal or therapeutic concentration in blood and inhibit parasite in the various stage of parasite's life cycle. This provides availability of drugs in blood longer so that the therapeutic effect can be maintained.

Conclusion {#sec1-5}
==========

*C. spectabilis* is potential candidate for antimalarial agent. The antimalarial effective dose of ethanol extract of *C. spectabilis* leaves in *P.berghei*-infected mice is 150 mg/kg bodyweight with thrice daily administration.
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